TissueTech, Inc. is the forefront in pioneering technologies utilizing items derived from human amniotic and umbilical cord tissues. Since its establishment in 1997, the organization has been at the forefront of applying human placental tissues in clinical settings – over 300,000 individuals have received treatment with TissueTech products, and the company’s revolutionary scientific and clinical accomplishments have been detailed in more than 300 peer-reviewed publications.